Dianthus Therapeutics Announces Two Poster Presentations For DNTH103 At The 10th Congress Of The European Academy Of Neurology June 29-July 2, 2024
Portfolio Pulse from Benzinga Newsdesk
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) announced two poster presentations for its drug candidate DNTH103 at the 10th Congress of the European Academy of Neurology, scheduled for June 29-July 2, 2024, in Helsinki.
June 28, 2024 | 3:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dianthus Therapeutics will present two posters on DNTH103 at a major neurology congress in June 2024, potentially increasing visibility and interest in their drug candidate.
Presenting at a major congress can increase visibility and credibility for DNTH103, potentially attracting investor interest and positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100